![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
X
20
Ajinomoto Co., Inc. Tokyo Jp, based in Japan, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their significant offerings is Alanine, II, supported by a 'Valid' Certificate of Suitability (CEP) with the number CEP 2018-145 - Rev 01
This Chemical Type CEP, issued on December 20, 2023, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.
Substance Number 752 associated with this CEP further emphasizes